[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341034-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341034-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","igf2bp3-prevent-hmgb1-mrna-decay-in-bladder-cancer-and-development","IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development","","IGF2BP3 is an RNA-binding protein involved in posttranscriptional regulation of mRNA stability, localization, and translation, and its dysregulation links to tumorigenesis. However, the mechanisms controlling IGF2BP3 expression remain unclear. This study evaluates IGF2BP3 regulation in bladder cancer and development, demonstrating elevated IGF2BP3 levels, its functional acceleration of tumor progression, and the HMGB1 axis as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/igf2bp3-prevent-hmgb1-mrna-decay-in-bladder-cancer-and-development/341034/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/igf2bp3-prevent-hmgb1-mrna-decay-in-bladder-cancer-and-development/341034.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does IGF2BP3 play in bladder cancer?","Question",{"text":63,"@type":64},"IGF2BP3 is a dysregulated RNA-binding protein whose increased expression correlates with more advanced bladder cancer and unfavorable prognosis. Functionally, it promotes proliferation, migration, and invasion while IGF2BP3 silencing shows the opposite effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is IGF2BP3 expression regulated according to the study?",{"text":68,"@type":64},"IGF2BP3 upregulation is associated with copy number gain/amplification and promoter hypomethylation. The study also identifies miR-320a-3p as another negative regulator in bladder cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is HMGB1 important in the IGF2BP3 mechanism?",{"text":72,"@type":64},"IGF2BP3 enhances HMGB1 mRNA stability by binding its mRNA, supporting HMGB1-driven inflammation and tumorigenesis. Pharmacological inhibition of HMGB1 with glycyrrhizin reverses the cancer-promoting effects of IGF2BP3 overexpression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341034,1790211487,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Lv et al. Cellular & Molecular Biology Letters (2024) 29:39 [https://doi.org/10.1186/s11658-024-00545-1](https://doi.org/10.1186/s11658-024-00545-1)  \nCellular & Molecular Biology Letters  \nRESEARCH ARTICLE Open Access  \nIGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development  \nLei Lv1†, Qinqin Wei2†, Jianxiao Zhang3†, Yitong Dong2, Zhenglei Shan4, Na Chang5, Ye Zhao2*, Po Bian2* and Qiyi Yi2*  \n\n| †Lei Lv, Qinqin Wei and Jianxiao Zhang are contributed equally to this work. |\n| --- |\n| *Correspondence: [zhaoye@ahmu.edu.cn](zhaoye@ahmu.edu.cn); [bianpo@ahmu.edu.cn](bianpo@ahmu.edu.cn); [yiqiyi@ahmu.edu.cn](yiqiyi@ahmu.edu.cn) |\n\n1 Department of Cancer Epigenetics Program, Anhui Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230031, Anhui, China  \n2 Institute of Radiation Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, Anhui, China  \n3 Medical Consulting Center, Hebei Children’s Hospital, Shijiazhuang 050030, Hebei, China  \n4 The Second Clinical College, Anhui Medical University, Hefei 230032, Anhui, China  \n5 Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230031, Anhui, People’s Republic of China  \nAbstract  \nBackground: IGF2BP3 functions as an RNA-binding protein (RBP) and plays a role in the posttranscriptional control of mRNA localization, stability, and translation. Its dysregulation is frequently associated with tumorigenesis across various cancer types. Nonetheless, our understanding of how the expression ofthe IGF2BP3 gene is regulated remains limited. The specific functions and underlying mechanisms of IGF2BP3, as well as the potential benefits of targeting it for therapeutic purposes in bladder cancer, are not yet well comprehended.  \nMethods: The mRNA and protein expression were examined by RT-qPCR and western blotting, respectively. The methylation level of CpG sites was detected by Bisulfite sequencing PCR (BSP) . The regulation of IGF2BP3 expression by miR-320a-3p was analyzed by luciferase reporter assay. The functional role of IGF2BP3 was determined through proliferation, colony formation, wound healing, invasion assays, and xenograft mouse model. The regulation of HMGB1 by IGF2BP3 was investigated by RNA immunoprecipitation (RIP) and mRNA stability assays.  \nResults: We observed a significant elevation in IGF2BP3 levels within bladder cancer samples, correlating with more advanced stages and grades, as well as an unfavorable prognosis. Subsequent investigations revealed that the upregulation of IGF2BP3 expression is triggered by copy number gain/amplification and promoter hypomethylation in various tumor types, including bladder cancer. Furthermore, miR-320a-3p was identified as another negative regulator in bladder cancer. Functionally, the upregulation of IGF2BP3 expression exacerbated bladder cancer progression, including the proliferation, migration, and invasion of bladder cancer. Conversely, IGF2BP3 silencing produced the opposite effects. Moreover, IGF2BP3 expression positively correlated with inflammation and immune infiltration in bladder cancer. Mechanistically, IGF2BP3 enhanced mRNA stability and promoted the expression of HMGB1 by binding to its mRNA, which is a factor that promotes inflammation and orchestratestumorigenesis in many cancers. Importantly, pharmacological inhibition of HMGB1 with glycyrrhizin, a specific HMGB1 inhibitor, effectively reversed the cancer-promoting effects of IGF2BP3 overexpression in bladder cancer. Furthermore, the relationship between HMGB1 mRNA and IGF2PB3 is also observed in mammalian embryonic development, with the expression of both genes gradually decreasing as embryonic development progresses.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 Intern","cbCaikX314HNGKl7","https://ap.wps.com/l/cbCaikX314HNGKl7","pdf",12451214,29,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background (Graphical Abstract)","[{\"question\":\"What role does IGF2BP3 play in bladder cancer?\",\"answer\":\"IGF2BP3 is a dysregulated RNA-binding protein whose increased expression correlates with more advanced bladder cancer and unfavorable prognosis. Functionally, it promotes proliferation, migration, and invasion while IGF2BP3 silencing shows the opposite effects.\"},{\"question\":\"How is IGF2BP3 expression regulated according to the study?\",\"answer\":\"IGF2BP3 upregulation is associated with copy number gain/amplification and promoter hypomethylation. The study also identifies miR-320a-3p as another negative regulator in bladder cancer.\"},{\"question\":\"Why is HMGB1 important in the IGF2BP3 mechanism?\",\"answer\":\"IGF2BP3 enhances HMGB1 mRNA stability by binding its mRNA, supporting HMGB1-driven inflammation and tumorigenesis. Pharmacological inhibition of HMGB1 with glycyrrhizin reverses the cancer-promoting effects of IGF2BP3 overexpression.\"}]","IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development | PDF",1790040033,73,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5620330d6c961f971f36ce5df0bc09ba.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3da3d1e60f99fc4567d6bd7332f1ff5d.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f4c78bf16c9ea0a25a915df28c28858.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9f738bb483e7e9deb997a51253e3696.webp",980,1301]